Abstract
In todays drug discovery projects, the use of virtual screening tools, either ligand-based or structure-based techniques, is gaining momentum. Taken separately, these techniques obviously present some genuine advantages on some specific tasks, for example and for a given target, it is possible to explore the local variation of the chemical space in terms of structure activity relationship (SAR), or to sample the pharmaco-topological profile of potential hit molecules in a target structure driven manner (docking). Thus, while inherent limits are associated with each of these screening techniques that are not about to be easily solved, their combination in a hybrid protocol can help to balance these limitations and capitalize on their mutual strengths. Here we review some recent studies integrating ligand- and structure-based screening protocols, and show how this concept directly benefits the quality of the hit molecules.
Keywords: Drug design, structure-based drug design, ligand-based drug design, pharmacophore, QSAR, virtual screening, combination
Current Computer-Aided Drug Design
Title: Combining Ligand- and Structure-Based Methods in Drug Design Projects
Volume: 4 Issue: 3
Author(s): Olivier Sperandio, Maria A. Miteva and Bruno O. Villoutreix
Affiliation:
Keywords: Drug design, structure-based drug design, ligand-based drug design, pharmacophore, QSAR, virtual screening, combination
Abstract: In todays drug discovery projects, the use of virtual screening tools, either ligand-based or structure-based techniques, is gaining momentum. Taken separately, these techniques obviously present some genuine advantages on some specific tasks, for example and for a given target, it is possible to explore the local variation of the chemical space in terms of structure activity relationship (SAR), or to sample the pharmaco-topological profile of potential hit molecules in a target structure driven manner (docking). Thus, while inherent limits are associated with each of these screening techniques that are not about to be easily solved, their combination in a hybrid protocol can help to balance these limitations and capitalize on their mutual strengths. Here we review some recent studies integrating ligand- and structure-based screening protocols, and show how this concept directly benefits the quality of the hit molecules.
Export Options
About this article
Cite this article as:
Sperandio Olivier, Miteva A. Maria and Villoutreix O. Bruno, Combining Ligand- and Structure-Based Methods in Drug Design Projects, Current Computer-Aided Drug Design 2008; 4 (3) . https://dx.doi.org/10.2174/157340908785747447
DOI https://dx.doi.org/10.2174/157340908785747447 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Determinants of Selective Agonist and Antagonist Binding to the Histamine H4 Receptor
Current Topics in Medicinal Chemistry Rheumatoid Nodules and Lung
Current Respiratory Medicine Reviews Molecular Pathways of Endothelial Cell Activation for (Targeted) Pharmacological Intervention of Chronic Inflammatory Diseases
Current Vascular Pharmacology Possible Effect of Astaxanthin on Obesity-related Increased COVID-19 Infection Morbidity and Mortality
Current Nutrition & Food Science Impact of Novel Screening Technologies on Ion Channel Drug Discovery
Combinatorial Chemistry & High Throughput Screening Lung Pneumonitis and Fibrosis in Cancer Therapy: A Review on Cellular and Molecular Mechanisms
Current Drug Targets Recent Advances in Anti-inflammatory Potential of Pyridazinone Derivatives
Mini-Reviews in Medicinal Chemistry Biological Activities and Corresponding SARs of Andrographolide and Its Derivatives
Mini-Reviews in Medicinal Chemistry Design, Synthesis and Biological Evaluation of Ligands Selective for the Melanocortin-3 Receptor
Current Topics in Medicinal Chemistry Nanotechnology-based Herbal Formulations: A Survey of Recent Patents, Advancements, and Transformative Headways
Recent Patents on Nanotechnology Ligand Based Validated Comparative Chemometric Modeling and Pharmacophore Mapping of Aurone Derivatives as Antimalarial Agents
Current Computer-Aided Drug Design On the Discovery and Development of CFTR Chloride Channel Activators
Current Pharmaceutical Design Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
Current Medicinal Chemistry Computational Methods in the Discovery and Design of BACE-1 Inhibitors
Current Medicinal Chemistry Phytohormone Crosstalk Research: Cytokinin and its Crosstalk with Other Phytohormones
Current Protein & Peptide Science Recent Advances in the Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses
Current Topics in Medicinal Chemistry Fragment-Based Optimization of Small Molecule CXCL12 Inhibitors for Antagonizing the CXCL12/CXCR4 Interaction
Current Topics in Medicinal Chemistry Renal Involvement in Pediatric Patients with COVID-19: An Up-to-date Review
Current Pediatric Reviews A Journey of Coronaviruses from Sporadic Outbreaks to COVID-19 Pandemic
Coronaviruses Biomarker Discovery and Translation in Metabolomics
Current Metabolomics